The Translational Research Partnership Program supports collaborative projects in cancer research to help accelerate the development of new treatments and/or technologies for the benefit of patients. Our Translational Research Partnership strategy is bold and ambitious. We aim to break down the boundaries between research disciplines, which may include researchers from non-cancer backgrounds, in order to find innovative solutions to prevent, detect and treat cancer. We partner with a range of organizations to maximize the impact of research on patient outcomes.
Goal: To support collaborative and pivotal translational research projects
Total budget: A maximum of $1,500,000 over up to 3 years per project of which up to 50% may come from the Cancer Research Society
Applicant Eligibility: All applicants and co-applicants must hold an academic appointment at a Canadian university or accredited research institutions
Project Eligibility: Projects must meet the following conditions:
Research Team: The research team must consist of at least one principal investigator and one co-investigator. The inclusion of a variety of non-cancer disciplines is encouraged to drive the development of novel technologies and to take thinking from other fields that have not yet been applied to cancer.
Selection Criteria: All projects are evaluated based on the following criteria:
Application Deadline: There is no deadline associated with this program
An application for the Translational Research Partnership Program requires a Letter of Intent. The Cancer Research Society’s Scientific Advisory Committee reviews all Letters of Intent, after which applicants with high potential projects are invited to submit an official application for funding, which is then peer-reviewed.
We encourage you to discuss your project with us.
Please contact us by email: Partnerships@src-crs.ca
Lynda Adam PhD, Director of partnerships